Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore

Drug Metabolism and Pharmacokinetics

Volumn 25, Issue 1, 2010, Pages 112-119

  Toh, Dorothy Su Lin ^a,b   Yee, Jie Yin ^a   Koo, Seok Hwee ^a   Murray, Michael ^a   Lee, Edmund Jon Deoon ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical pharmacology; Human genetics; OCTN2; Pharmacogenetics; Single nucleotide polymorphism; SLC22 transporters

Indexed keywords

MEMBRANE PROTEIN; ORGANIC CATION TRANSPORTER 2; PROTEIN SLC22A5; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CHINESE; CODON; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; INDIAN; MALE; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77949285973     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.25.112     Document Type: Article

References (32)

1. Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y. and Tsuji, A.: Molecular and functional identification of sodium ion-dependent, high-affinity human carnitine transporter OCTN2. J. Biol. Chem., 273: 20378-20382 (1998).
2. Wu, X., Huang, W., Prasad, P. D., Seth P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J. and Ganapathy, V.: Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther., 290: 1482-1492 (1999).
3. Ohashi, R., Tamai, I., Nezu, J. J., Nikaido, H., Hashimoto, N., Oku, A., Sai, Y., Shimane, M. and Tsuji, A.: Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol. Pharmacol., 59: 358-366 (2001).
4. +)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J. Pharmacol. Exp. Ther., 291: 778-784 (1999).
5. Saito, S., Iida, A., Sekine, A., Ogawa, C., Kawauchi, S., Higuchi, S. and Nakamura, Y.: Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in the Japanese population. J. Hum. Genet., 47: 576-584 (2002).
6. Peluso, G., Nicolai, R., Reda, E., Benatti, P., Barbarisi, A. and Calvani, M.: Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J. Cell. Physiol., 182: 339-350 (2000).
7. Koepsell, H., Lips, K. and Volk, C.: Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res., 24: 1227-1251 (2007).
8. Meier, Y., Eloranta, J. J., Darimont, J., Ismair, M. G., Hiller, C., Fried, M., Kullak-Ublick, G. A. and Stephan, R.: Vavricka regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab. Dispos., 35: 590-594 (2007).
9. Englund, G., Rorsman, F., Ronnblom, A., Karlbom, U., Lazorova, L., Grasjo, J., Kindmark, A. and Artursson, P.: Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur. J. Pharm. Sci., 29: 269-277 (2006).
10. Evans, A. M. and Fornasini, G.: Pharmacokinetics of L-carnitine. Clin. Pharmacokinet., 42: 941-967 (2003).
11. Lamhonwah, A.-M., Olpin, S. E., Pollitt, R. J., Vianey-Saban, C., Divry, P., Guffon, N., Besley, G. T., Onizuka, R., De Meirleir, L. J., Cvitanovic-Sojat, L., Baric, I., Dionisi-Vici, C., Fumic, K., Maradin, M. and Tein, I.: Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am. J. Med. Genet., 111: 271-284 (2002).
12. Grube, M., Schwabedissen, H. M., Draber, K., Praäger, D., Moä ritz, K. U., Linnemann, K., Fusch, C., Jedlitschky, G. and Kroemer, H. K.: Expression, localization, and function of the Carnitine transporter OCTN2 (SLC22A5) in human placenta. Drug Metab. Dispos., 33: 31-37 (2005).
13. Nakano, C., Takashima, S. and Takeshita, K.: Carnitine concentration during the development of human tissues. Early Hum. Dev., 19: 21-27 (1989).
14. Bremer, J.: Carnitine metabolism and functions. Physiol. Rev., 63: 1420-1480 (1983).
15. Lahjouji, K., Mitchell, G. A. and Qureshi, I. A.: Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol. Genet. Metab., 73: 287-297 (2001).
16. Tein, I.: Carnitine transport: pathophysiology and metabolism of known molecular defects. J. Inherit. Metab. Dis., 26: 147-169 (2003).
17. Koizumi, A., Nozaki, J., Ohura, T., Kayo, T., Wada, Y., Nezu, J., Ohashi, R., Tamai, I., Shoji, Y., Takada, G., Kibira, S., Matsuishi, T. and Tsuji, A.: Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum. Mol. Genet., 8: 2247-2254 (1999).
18. Wilcken, B., Wiley, V., Sim, K. G. and Carpenter, K.: Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J. Pediatr., 138: 581-584 (2001).
19. Tang, N. L., Ganapathy, V., Wu, X., Hui, J., Seth, P., Yuen, P. M., Wanders, R. J., Fok, T. F. and Hjelm, N. M.: Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum. Mol. Genet., 8: 655-660 (1999).
20. Urban, T. J., Gallagher, R. C., Brown, C., Castro, R. A., Lagpacan, L. L., Brett, C.M., Travis, R. T., Carlson, E. J., Ferrin, T. E., Burchard, E. G., Packman, S. and Kathleen, M.: Giacomini. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5). Mol. Pharmacol., 70: 1602-1611 (2006).
21. Amat di San Filippo, C., Taylor, M. R. G., Mestroni, L., Botto, L. D. and Longo, N.: Cardiomyopathy and carnitine deficiency. Mol. Genet. Metab., 94: 162-166 (2008).
22. Amat di San Filippo, C., Pasquali, M. and Longo, N.: Pharmacological rescue of carnitine transport in primary carnitine deficiency. Hum. Mutat., 27: 513-523 (2006).
23. Wang, Y., Taroni, F., Garavaglia, B. and Longo, N.: Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype-phenotype correlation. Hum. Mutat., 16: 401-407 (2000).
24. Barrett, J. C., Fry, B., Maller, J. and Daly, M. J.: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics., 21: 263-265 (2005).
25. Shoji, Y., Koizumi, A., Kayo, T., Ohata, T., Takahashi, T., Harada, K. and Takada, G.: Evidence for linkage of human primary systemic carnitine deficiency with D5S436. A novel gene locus on chromosome 5q. Am. J. Hum. Genet., 63, 101-108 (1998).
26. Vaz, F. M., Scholte, H. R., Ruiter, J., Hussaarts-Odijk, L. M., Pereira, R. R., Schweitzer, S., de Klerk, J. B., Waterham, H. R. and Wanders, R. J.: Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. Hum. Genet., 105: 157-161 (1999).
27. Burwinkel, B., Kreuder, J., Schweitzer, S., Vorgerd, M., Gempel, K., Gerbitz, K. D. and Kilimann, M. W.: Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality. Biochem. Biophys. Res. Commun., 161: 484-487 (1999).
28. Tang, N. L. S., Hwu, W. L., Chan, R. T., Law, L. K., Fung, L. M. and Zhang, W. M.: A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients. Hum. Mutat., 20: 232-239 (2002).
29. Klein, T. E., Chang, J. T., Cho, M. K., Easton, K. L, Fergerson, R., Hewett, M., Lin, Z., Liu, Y., Liu, S., Oliver, D. E., Rubin, D. L., Shafa, F., Stuart, J. M. and Altman, R. B.: Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenomics J., 1: 167-170 (2001).
30. The International HapMap Consortium: The International Hap-Map Project. Nature., 426: 789-796 (2003).
31. Toh, S. L., Koo, S. H., Limenta, L. M. G., Yee, J. Y., Murray, M. and Lee, J. D.: Genetic variations of the SLC22A4 gene in the Chinese and Indian populations of Singapore. Drug Metab. Pharmacokinet., 24(5): 475-481 (2009).
32. Onnie, C., Fisher, S. A., King, K., Mirza, M., Roberts, R., Forbes, A., Sanderson, J., Lewis, C. M. and Mathew, C. G.: Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31. Genes Immun., 7: 359-365 (2006).